Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 23 (RPL36AP23)

Target
RPL36AP23
Molecular classification
Other (Pseudogene)
01

Overview

**Ribosomal protein L36a pseudogene 23 (RPL36AP23)** is a processed pseudogene of the RPL36A gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis[4][3]. Pseudogenes like RPL36AP23 do not produce functional proteins and generally lack known biological functions, drug interactions, or disease associations[4]. As a pseudogene, it is not considered a therapeutic target, and there is no evidence to suggest clinical or pharmacological relevance[3][4]. **Notes:** - This entry corresponds to a pseudogene, not a functional protein or receptor; pseudogenes are typically not considered valid drug targets because they do not encode active biomolecules[4]. - There is no evidence linking RPL36AP23 with disease, therapeutic intervention, or biomarkers; these associations are known for some functional ribosomal proteins, not pseudogenes like RPL36AP23[4]. - If a functional or disease-associated ribosomal protein is intended (e.g., RPL36A, RPL36AL), please clarify the query, as those have distinct molecular and clinical properties[4][7].

Other names
RPL36A_6_507RPL36AP23

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 23 (RPL36AP23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 23 (RPL36AP23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call